These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6199652)

  • 41. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW; Card JL; Morgan DO
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lower anti-echovirus antibody responses in children presenting to hospital with asthma exacerbations.
    Iwasaki J; Chai LY; Khoo SK; Bizzintino J; Laing IA; Le Souëf PN; Thomas WR; Hales BJ
    Clin Exp Allergy; 2015 Oct; 45(10):1523-30. PubMed ID: 25640320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Steady-state infection by echovirus 6 associated with nonlytic viral RNA and an unprocessed capsid polypeptide.
    Righthand VF; Blackburn RV
    J Virol; 1989 Dec; 63(12):5268-75. PubMed ID: 2585604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a neutralization-specific antigen of a calf rotavirus.
    Killen HM; Dimmock NJ
    J Gen Virol; 1982 Oct; 62 (Pt 2)():297-311. PubMed ID: 6292353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relatedness of glycoproteins expressed on the surface of simian herpes-virus virions and infected cells to specific HSV glycoproteins.
    Eberle R; Black D; Hilliard JK
    Arch Virol; 1989; 109(3-4):233-52. PubMed ID: 2482016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of three antigenic particles of swine vesicular disease virus.
    Moore DM
    J Gen Virol; 1977 Mar; 34(3):431-45. PubMed ID: 67181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemistry and pathogenicity of echovirus 9. II. Mutants of echovirus 9, strain Hill, with altered capsid surface properties.
    Rosenwirth B; Eggers HJ
    Virology; 1986 Sep; 153(2):248-55. PubMed ID: 3739228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
    Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
    Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenic comparison of the polypeptides of foot-and-mouth disease virus serotypes and other picornaviruses.
    Grubman MJ; Zellner M; Wagner J
    Virology; 1987 May; 158(1):133-40. PubMed ID: 2437694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.
    Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F
    Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poliovirus empty capsid morphogenesis: evidence for conformational differences between self- and extract-assembled empty capsids.
    Putnak JR; Phillips BA
    J Virol; 1982 Mar; 41(3):792-800. PubMed ID: 6284971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71.
    Zhang J; Dong M; Jiang B; Dai X; Meng J
    Virus Res; 2012 Aug; 167(2):337-42. PubMed ID: 22659489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological studies of the group B coxsackieviruses by the sandwich enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation.
    Katze MG; Crowell RL
    J Gen Virol; 1980 Oct; 50(2):357-67. PubMed ID: 6161989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Candidate recombinant vaccine for human B19 parvovirus.
    Bansal GP; Hatfield JA; Dunn FE; Kramer AA; Brady F; Riggin CH; Collett MS; Yoshimoto K; Kajigaya S; Young NS
    J Infect Dis; 1993 May; 167(5):1034-44. PubMed ID: 8486937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic determinants of adenovirus capsids. II. Homogeneity of hexons, and accessibility of their determinants, in the virion.
    Willcox N; Mautner V
    J Immunol; 1976 Jan; 116(1):25-9. PubMed ID: 54389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens.
    Li F; Stevenson RA; Crabb BS; Studdert MJ; Hartley CA
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):778-85. PubMed ID: 15939754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Canine parvovirus capsid assembly and differences in mammalian and insect cells.
    Yuan W; Parrish CR
    Virology; 2001 Jan; 279(2):546-57. PubMed ID: 11162810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antigenic epitopes of the hepatitis A virus polyprotein.
    Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
    Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.